等待开盘 11-03 09:30:00 美东时间
+0.660
+1.01%
AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action.A novel differentiated synthetic
10-28 20:51
(来源:东北通信科技最前沿) 报告摘要: OCS光交换是一种无需光电/电光(O/E/O)转换,直接实现光信号在光纤端口间切换的技术。OCS原理是直接...
10-23 12:06
诺诚健华(上交所代码:688428;香港联交所代码:09969)新型BTK抑制剂奥布替尼和坦昔妥单抗的多项研究数据在2025年欧洲肿瘤内科学会(ESMO)年会上...
10-17 09:42
LAUSANNE, Switzerland, Oct. 13, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ann...
10-13 19:30
CervoMed's Phase 2b trial shows neflamapimod reduces dementia progression and plasma GFAP, with significant cognitive improvements in Lewy body dementia patients.
10-08 23:54
In the preceding three months, 4 analysts have released ratings for Adaptive Bi...
10-01 04:00
诺诚健华(09969)早盘股价上涨7.18%,现报18.97港元,成交额1.35亿港元。 据诺诚健华官微消息,近日,公司宣布,靶向CD19单抗明诺凯®(坦昔...
09-30 10:40
[ 编者按 ] 创业之路从不缺热情与创意,却常困于方向的迷茫,核心症结始终是“如何找到产品与市场的契合点(PMF),并选对商业化路径”。 这份困惑,正是MI...
09-30 08:02
登录新浪财经APP 搜索【信披】查看更多考评等级 本文授权来自《中国民商》 作者:郑勇康 编辑:张佳茗 广州必贝特医药股份有限公司...
09-29 15:36
转自:扬子晚报 近日,QQ音乐、杜比实验室(Dolby Laboratories)携手,针对车载端全球首发袁娅维全新英文单曲《PRESSURE》,开启“上车...
09-28 14:51